Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Other Current Assets

$1.35M

Quarterly · Period ending: · USD

LCTX logo

LCTX Other Current Assets

Latest reported$1.35M
LCTX Quarterly Other Current Assets ($100.00K → $1.35M)
High-resolution chart · PNG

LCTX other current assets history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Other Current Assets — Quarterly (USD)
Period endingOther Current Assets (USD)
1,351,000
1,977,000
1,814,000
1,647,000
1,300,000
1,866,000
2,554,000
1,285,000
1,659,000
2,018,000
2,204,000
1,717,000
2,123,000
2,638,000
1,828,000
1,720,000
1,289,000
1,413,000
2,051,000
3,161,000
2,505,000
2,149,000
2,433,000
1,414,000
1,377,000
2,225,000
2,063,000
2,342,000
2,101,000
4,316,000
1,898,000
1,761,000
1,225,000
1,403,000
1,402,000
1,354,000
6,689,000
1,513,000
1,777,000
2,079,000
1,787,000
2,878,000
3,177,000
1,752,000
1,492,000
1,271,895
1,607,000
1,255,479
1,476,104
1,554,114
1,160,589
1,413,729
3,760,667
3,018,421
2,774,196
1,861,407
1,891,383
2,101,905
2,692,303
2,263,782
1,981,199
2,407,270
2,202,284
983,933
880,571
168,844
138,547
117,672
45,784
109,277
96,595
37,114
150,626
210,588
132,145
13,883
37,131
53,246
57,675
49,449
104,201
141,979
97,856
109,202
111,664
111,507
122,225
26,817
65,437
108,360
289,865
38,285
67,259
86,883
97,686
4,090
83,198
117,639
109,430
251,794
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.